Owkin is a life sciences technology company that develops agentic AI to accelerate biomedical research, drug discovery, development, and diagnostics. It leverages multimodal patient data and diverse biological samples from academic partners to power its AI insights, aiming to reveal causal relationships and actionable findings across biology. The company operates globally with data networks and software platforms like K Pro to drive decision-making across pharma, diagnostics, and research teams.
No recent deals for this company.